Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunologic Markers”

146 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 146 results

Post-approval studies (Phase 4)Study completedNCT02234492
What this trial is testing

The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients

Who this might be right for
Human Immunodeficiency Virus (HIV)Cardiovascular Disease (CVD)
Ottawa Heart Institute Research Corporation 35
Testing effectiveness (Phase 2)Study completedNCT03181009
What this trial is testing

Multi OIT to Test Immune Markers After Minimum Maintenance Dose

Who this might be right for
Food Allergy
Andrew Long, PharmD 60
Not applicableStudy completedNCT03445351
What this trial is testing

Quality of Life, Sleep, and Biomarkers in People With HIV/AIDS

Who this might be right for
HIV/AIDS and InfectionsDisorder SleepLipodystrophy
JULIANY DE SOUZA ARAUJO 17
Not applicableUnknownNCT02005094
What this trial is testing

The Role of Inflammasome in Inflammatory Macrophage in Mycobacterium Avium Complex-lung Disease and Mycobacterium Abscessus-lung Disease

Who this might be right for
To Investigate the Inflammasome Response of Inflammatory and Resting MacrophageTo Compare the Difference of Inflammasome Response of Inflammatory MacrophageTo Study the Diagnostic Aid From Immunological Markers in Inflammasome Response
National Taiwan University Hospital 100
Not applicableStudy completedNCT00343317
What this trial is testing

Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women

Who this might be right for
Puerperal Sepsis
University of KwaZulu 1,372
Not applicableStudy completedNCT01252992
What this trial is testing

Paradoxical Reactions in Non Immuno-compromized Patients With Extrapulmonary Tuberculosis

Who this might be right for
Extrapulmonary Tuberculosis
Assistance Publique - Hôpitaux de Paris 135
Very early researchEnded earlyNCT00871533
What this trial is testing

Pilot Study of IFN α2b for Melanoma Patients

Who this might be right for
Melanoma
University of Pittsburgh 50
Testing effectiveness (Phase 2)Study completedNCT00002390
What this trial is testing

The Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome
Not applicableUnknownNCT04548960
What this trial is testing

OncoSNIPE - Study of Molecular Profiles Associated With the Development of Resistance in Solid Cancer Patients

Who this might be right for
CANCER
Oncodesign SA 600
Not applicableStudy completedNCT00001393
What this trial is testing

Genetic Markers for Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental GlomerulosclerosisHIV-Associated Focal Segmental Glomerulosclerosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 616
Not applicableUnknownNCT06421259
What this trial is testing

Descriptive Analysis of Changes in Hepatitis B Markers in People Living With HIV on Injectable Therapy.

Who this might be right for
Hiv InfectionHepatitis B
Centre Hospitalier Universitaire de Nice 15
Not applicableStudy completedNCT02440126
What this trial is testing

Longitudinal Analysis And Sample Collection To Evaluate PML Risk Host Markers for PML Risk Host Markers for PML Risk

Who this might be right for
Multiple Sclerosis
Rocky Mountain MS Research Group, LLC 196
Not applicableStudy completedNCT01177124
What this trial is testing

Mindfulness-Based Stress Reduction (MBSR) Symptom Cluster Trial for Breast Cancer Survivors

Who this might be right for
Breast Cancer
Cecile Lengacher 300
Not applicableUnknownNCT05719025
What this trial is testing

Markers of Neurological Damage Post Covid-19 in PLWH

Who this might be right for
COVID-19Hiv
Scientific Institute San Raffaele 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07598032
What this trial is testing

Comparative Analysis of Immunological Responses to Vitamin D Replacement Therapy in Black and West African Men Diagnosed With Prostate Cancer: Elucidating Differential Effects on Immune Function Between Patients With Localized Disease and Those With Metastatic Progression

Who this might be right for
Prostate Cancer (Adenocarcinoma)Vitamin D on Tumor Response and Inflammatory Markers
University of Ilorin Teaching Hospital 200
Testing effectiveness (Phase 2)Study completedNCT04585789
What this trial is testing

Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B
Janssen Research & Development, LLC 24
Not applicableLooking for participantsNCT07477925
What this trial is testing

Immunological and Virological Prognostic Markers of Human Cytomegalovirus (HCMV) Congenital Infection in Pregnant Women With Primary HCMV Infection.

Who this might be right for
Human Cytomegalovirus (HCMV)
Fondazione IRCCS Policlinico San Matteo di Pavia 90
Testing effectiveness (Phase 2)Study completedNCT02121756
What this trial is testing

Dipyridamole for Immune Activation in HIV

Who this might be right for
HIV Infection
Sharon Riddler 40
Not applicableStudy completedNCT05369156
What this trial is testing

The Effects of Chiropractic Care in Adults With Subclinical Spinal Pain

Who this might be right for
Subclinical Spinal Pain
Riphah International University 120
Testing effectiveness (Phase 2)Study completedNCT00518154
What this trial is testing

Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response

Who this might be right for
HIV Infections
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 7
Next Page